Search Results

There are 12675 results for: content related to: Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells

  1. You have free access to this content
    Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation

    British Journal of Clinical Pharmacology

    Volume 80, Issue 5, November 2015, Pages: 1097–1108, Jan H. Beumer, Venkateswaran C. Pillai, Robert A. Parise, Susan M. Christner, Brian F. Kiesel, Michelle A. Rudek and Raman Venkataramanan

    Version of Record online : 19 SEP 2015, DOI: 10.1111/bcp.12723

  2. You have free access to this content
    Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates

    British Journal of Pharmacology

    Volume 165, Issue 8, April 2012, Pages: 2787–2798, AM Filppula, J Laitila, PJ Neuvonen and JT Backman

    Version of Record online : 23 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01732.x

  3. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells

    Journal of Cellular Physiology

    Volume 205, Issue 2, November 2005, Pages: 218–227, Faye M. Johnson, Babita Saigal and Nicholas J. Donato

    Version of Record online : 10 MAY 2005, DOI: 10.1002/jcp.20383

  4. Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 157–163, Y Yamakawa, A Hamada, T Shuto, M Yuki, T Uchida, H Kai, T Kawaguchi and H Saito

    Version of Record online : 1 JUN 2011, DOI: 10.1038/clpt.2011.102

  5. Co-encapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrin receptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatment

    Biotechnology and Bioengineering

    Volume 107, Issue 5, 1 December 2010, Pages: 884–893, Liliana S. Mendonça, João N. Moreira, Maria C. Pedroso de Lima and Sérgio Simões

    Version of Record online : 14 JUL 2010, DOI: 10.1002/bit.22858

  6. New insights into small-molecule inhibitors of Bcr-Abl

    Medicinal Research Reviews

    Volume 31, Issue 1, January 2011, Pages: 1–41, S. Schenone, O. Bruno, M. Radi and M. Botta

    Version of Record online : 27 AUG 2009, DOI: 10.1002/med.20175

  7. Chronic Myelogenous Leukemia

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt008

  8. You have free access to this content
    Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension

    British Journal of Clinical Pharmacology

    Volume 80, Issue 1, July 2015, Pages: 75–85, Didier Renard, Thomas Bouillon, Ping Zhou, Gerard Flesch and Debbie Quinn

    Version of Record online : 1 JUN 2015, DOI: 10.1111/bcp.12584

  9. Adiponectin enhances Imatinib anti-tumour activity in human chronic myeloid leukaemia cells with serum levels associated with Imatinib efficacy in early chronic phase patients

    Cell Proliferation

    Volume 48, Issue 4, August 2015, Pages: 486–496, Guangshan Tan, Lei Shi, Qiang Li and Mingjun Wang

    Version of Record online : 6 JUL 2015, DOI: 10.1111/cpr.12194

  10. You have free access to this content
    Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells

    Cancer

    Volume 106, Issue 5, 1 March 2006, Pages: 1188–1196, Alessandro Morotti, Daniela Cilloni, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Sonia Carturan, Renata Catalano, Valentina Rosso, Annalisa Chiarenza, Chiara Pilatrino, Angelo Guerrasio, Riccardo Taulli, Enrico Bracco, Marisa Pautasso, Daniela Baraban, Enrico Gottardi and Giuseppe Saglio

    Version of Record online : 27 JAN 2006, DOI: 10.1002/cncr.21725

  11. You have free access to this content
    Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

    Arthritis & Rheumatism

    Volume 56, Issue 1, January 2007, Pages: 311–322, Jörg H. W. Distler, Astrid Jüngel, Lars C. Huber, Ursula Schulze-Horsel, Jochen Zwerina, Renate E. Gay, Beat A. Michel, Thomas Hauser, Georg Schett, Steffen Gay and Oliver Distler

    Version of Record online : 28 DEC 2006, DOI: 10.1002/art.22314

  12. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  13. You have free access to this content
    Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase

    Cancer

    Volume 116, Issue 6, 15 March 2010, Pages: 1419–1430, Hagop M. Kantarjian, Jorge Cortes, Paul La Rosée and Andreas Hochhaus

    Version of Record online : 29 JAN 2010, DOI: 10.1002/cncr.24928

  14. Advanced or metastatic gastrointestinal stromal tumors: Systemic treatment options

    Journal of Surgical Oncology

    Volume 104, Issue 8, 15 December 2011, Pages: 888–895, Megan V. Caram and Scott M. Schuetze

    Version of Record online : 8 NOV 2011, DOI: 10.1002/jso.21930

  15. You have free access to this content
    Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein

    Cancer

    Volume 100, Issue 7, 1 April 2004, Pages: 1459–1471, Barbara Scappini, Simona Gatto, Francesco Onida, Clara Ricci, Vladimir Divoky, William G. Wierda, Michael Andreeff, Li Dong, Kimberly Hayes, Srdan Verstovsek, Hagop M. Kantarjian and Miloslav Beran

    Version of Record online : 25 FEB 2004, DOI: 10.1002/cncr.20131

  16. You have free access to this content
    Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 145, Issue 5, June 2009, Pages: 581–597, Franz Gruber, Satu Mustjoki and Kimmo Porkka

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1365-2141.2009.07666.x

  17. You have full text access to this OnlineOpen article
    Ageing is a risk factor in imatinib mesylate cardiotoxicity

    European Journal of Heart Failure

    Volume 16, Issue 4, April 2014, Pages: 367–376, Wael Maharsy, Anne Aries, Omar Mansour, Hiba Komati and Mona Nemer

    Version of Record online : 6 FEB 2014, DOI: 10.1002/ejhf.58

  18. You have free access to this content
    Despite Inhibition of Hematopoietic Progenitor Cell Growth In Vitro, the Tyrosine Kinase Inhibitor Imatinib Does Not Impair Engraftment of Human CD133+ Cells into NOD/SCIDβ2mNull Mice

    STEM CELLS

    Volume 24, Issue 7, July 2006, Pages: 1814–1821, Laurence Pirson, Frédéric Baron, Nathalie Meuris, Olivier Giet, Emilie Castermans, Roland Greimers, Ivano Di Stefano, André Gothot and Yves Beguin

    Version of Record online : 13 APR 2006, DOI: 10.1634/stemcells.2005-0290

  19. You have free access to this content
    Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor

    Cancer

    Volume 107, Issue 8, 15 October 2006, Pages: 1898–1908, Jonathan C. Trent, Latha Ramdas, Jheri Dupart, Kelly Hunt, Homer Macapinlac, Ellen Taylor, Limei Hu, August Salvado, James L. Abbruzzese, Raphael Pollock, Robert S. Benjamin and Wei Zhang

    Version of Record online : 19 SEP 2006, DOI: 10.1002/cncr.22214

  20. Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells

    Journal of Cellular Biochemistry

    Volume 95, Issue 2, 15 May 2005, Pages: 268–280, Kateřina Kuželová, Dana Grebeňová, Iuri Marinov and Zbyněk Hrkal

    Version of Record online : 15 MAR 2005, DOI: 10.1002/jcb.20407